Back to today’s briefing

Story perspectives

NDP52 Key to Alzheimer's Fight; Personalized Treatments Urged

5/4/2025

31 7

Summary

Story summary

NDP52 emerges as a key player in the fight against Alzheimer's disease, aiding in the removal of harmful phosphorylated Tau and thwarting its buildup. The ApoE4 Alzheimer’s Alliance calls for personalized treatments for those with the ApoE4 gene, stressing the importance of genetic testing. Furthermore, tackling accelerated biological aging through lifestyle changes could significantly lower dementia risk.

1 of 1

Story summary

NDP52 emerges as a key player in the fight against Alzheimer's disease, aiding in the removal of harmful phosphorylated Tau and thwarting its buildup. The ApoE4 Alzheimer’s Alliance calls for personalized treatments for those with the ApoE4 gene, stressing the importance of genetic testing. Furthermore, tackling accelerated biological aging through lifestyle changes could significantly lower dementia risk.